Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale (Q64860977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

P Hagell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Widner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

448-455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

Young onset Parkinson's disease

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Levodopa-induced dyskinesia: review, observations, and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Forms of dystonia in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Dystonia in Parkinson's disease: clinical and pharmacological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Effect of GPi pallidotomy on motor function in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Usefulness of pallidotomy in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Posteroventral medial pallidotomy in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Levodopa-induced dyskinesias are improved by fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Low-dose clozapine improves dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Assessment of extrapyramidal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Acute effects of pulsatile levodopa administration on central dopamine pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Core assessment program for intracerebral transplantations (CAPIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Lithium for painful dystonia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199905%2914%3A3%3C448%3A%3AAID-MDS1010%3E3.0.CO%3B2-0

10.1002/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348468%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference